Soleno Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Soleno Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Soleno Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Soleno Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.9M | 58k | 67.60 |
| 2025-06-30 | $7.5M | 89k | 83.78 |
| 2025-03-31 | $2.9M | 41k | 71.45 |
| 2024-12-31 | $1.2M | 28k | 44.95 |
| 2024-09-30 | $1.1M | 22k | 50.49 |
| 2024-06-30 | $960k | 24k | 40.80 |
| 2024-03-31 | $378k | 8.8k | 42.80 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas